← Insider buys

TNDM

Tandem Diabetes Care, Inc. · Healthcare

No insider bought or sold Tandem Diabetes Care, Inc. in the last 12 months

$0Bought, 12 mo
$0Sold, 12 mo
$1.1BMarket cap

TNDM over the last year

No insider buys filed in this year

TNDM after insider buys

3 months after each buy, from the first price a copier could get.

+10.3%Average
+4.0 ptsVs S&P 500
2 of 5Higher

5 buys since 2017 with 3 months of prices.

Congress

Members reported 7 trades in TNDM since 2023.

Every filing

172 insider filings since 2016, newest first

TNDMBuy

John F Sheridan · President and CEO

$102K+10.0%Aug 11
TNDMBuy

Leigh Vosseller · EVP and CFO

$149K+30.0%Aug 11
TNDMBuy

Jean-Claude Kyrillos · EVP and COO

$191KMar 11
TNDMSell

Kim D Blickenstaff · Director

$1.2M−19.0%Nov 22
TNDMSell

Dick Allen · Director

$258K−10.0%Jun 3
TNDMBuy

Peyton R Howell · Director

$90K+54.0%May 19
TNDMBuy

Leigh Vosseller · EVP and CFO

$99K+27.0%May 16
TNDMSell

David B Berger · EVP and COO

$412K−73.0%Mar 7
TNDMSell

David B Berger · EVP and COO

$1.0M−88.0%Dec 19
TNDMSell

David B Berger · EVP and COO

$657K−79.0%Jun 10
TNDMSell

Kim D Blickenstaff · Director

$1.0M−5.0%May 19
TNDMBuy

Leigh Vosseller · EVP and CFO

$187K+37.0%May 10
TNDMBuy

John F Sheridan · President and CEO

$175K+33.0%May 10
TNDMBuy

Peyton R Howell · Director

$150K+211.0%May 10
TNDMSell

Christopher J Twomey · Director

$28K−2.0%May 10
TNDMSell

Rebecca B Robertson · Director

$145K−100.0%May 4
TNDMSell

David B Berger · EVP and COO

$118K−17.0%Apr 5
TNDMSell

David B Berger · EVP and COO

$542K−50.0%Mar 21
TNDMSell

Kathleen Mcgroddy-Goetz · Director

$43K−33.0%Mar 16
TNDMSell

David B Berger · EVP and COO

$113K−17.0%Mar 2
TNDMSell

Rebecca B Robertson · Director

$177K−100.0%Feb 3
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$118K−18.0%Feb 3
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$149K−18.0%Jan 5
TNDMSell

Elizabeth Anne Gasser · EVP and Chief Strategy Officer

$164K−72.0%Dec 29
TNDMSell

James Leal · SVP, Operations

$289K−32.0%Dec 29
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$1.7M−72.0%Dec 17
TNDMSell

James Leal · SVP, Operations

$249K−32.0%Dec 1
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$128K−18.0%Dec 1
TNDMSell

Susan Morrison · EVP, Chief Admin. Officer

$4.9M−81.0%Nov 17
TNDMSell

Susan Morrison · EVP, Chief Admin. Officer

$763K−40.0%Nov 5
TNDMSell

Elizabeth Anne Gasser · EVP and Chief Strategy Officer

$3.1M−99.0%Nov 5
TNDMSell

Leigh Vosseller · EVP and CFO

$1.4M−61.0%Nov 5
TNDMSell

Rebecca B Robertson · Director

$204K−100.0%Nov 3
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$136K−18.0%Nov 3
TNDMSell

James Leal · SVP, Operations

$248K−34.0%Oct 28
TNDMSell

Susan Morrison · EVP, Chief Admin. Officer

$1.3M−55.0%Oct 14
TNDMSell

Leigh Vosseller · EVP and CFO

$2.7M−76.0%Oct 14
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$1.3M−69.0%Oct 14
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$118K−18.0%Oct 4
TNDMSell

James Leal · SVP, Operations

$232K−34.0%Sep 29
TNDMSell

Leigh Vosseller · EVP and CFO

$1.3M−61.0%Sep 17
TNDMSell

David B Berger · EVP, Bus Ops, Compliance

$1.1M−67.0%Sep 17
TNDMSell

Leigh Vosseller · EVP and CFO

$1.2M−61.0%Sep 15
TNDMSell

Brian B Hansen · EVP and Chief Commercial Officer

$3.8M−84.0%Sep 15
TNDMSell

James Leal · SVP, Operations

$440K−49.0%Sep 9
TNDMSell

Christopher J Twomey · Director

$37K−2.0%Sep 9
TNDMSell

Christopher J Twomey · Director

$1.0M−34.0%Sep 3
TNDMSell

Kim D Blickenstaff · Director

$3.3M−12.0%Sep 3
TNDMSell

James Leal · SVP, Operations

$184K−31.0%Aug 31
TNDMSell

David B Berger · EVP, Chief Business, Complianc

$1.1M−70.0%Aug 18
About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, Inc. designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. It's flagship products are the t:slim X2 insulin delivery system; and Tandem Mobi insulin pump, an automated insulin delivery system. The company also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, it offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. The company has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.